Fred Telling - 29 Jul 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: Director
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
Issuer symbol: OGEN
Transactions as of: 29 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Aug 2022, 16:35:34 UTC
Previous filing: 27 Jun 2022
Next filing: 10 Aug 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Non-Employee Director Option (Right to Buy)	Award	$0	+220,000		$0.000000	220,000	29 Jul 2022	Common Stock	220,000	$0.3562	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.